TY - JOUR T1 - Face Masks, Public Policies and Slowing the Spread of COVID-19: Evidence from Canada JF - medRxiv DO - 10.1101/2020.09.24.20201178 SP - 2020.09.24.20201178 AU - Alexander Karaivanov AU - Shih En Lu AU - Hitoshi Shigeoka AU - Cong Chen AU - Stephanie Pamplona Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/25/2020.09.24.20201178.abstract N2 - We estimate the impact of mask mandates and other non-pharmaceutical interventions (NPI) on COVID-19 case growth in Canada, including regulations on businesses and gatherings, school closures, travel and self-isolation, and long-term care homes. We partially account for behavioral responses using Google mobility data. Our identification approach exploits variation in the timing of indoor face mask mandates staggered over two months in the 34 public health regions in Ontario, Canada’s most populous province. We find that, in the first few weeks after implementation, mask mandates are associated with a reduction of 25 percent in the weekly number of new COVID-19 cases. Additional analysis with province-level data provides corroborating evidence. Counterfactual policy simulations suggest that mandating indoor masks nationwide in early July could have reduced the weekly number of new cases in Canada by 25 to 40 percent in mid-August, which translates into 700 to 1,100 fewer cases per week.JEL codes I18, I12, C23Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding external to the authors' home institution was received for this project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this manuscript is based on information available in public domain, and will be made available at the data availability link in the days following the posting of this manuscript. https://github.com/C19-SFU-Econ/Public-Data ER -